Meta-analysis of clinical trials assessing the safety of pharmacological treatments for muscular degeneration in Duchenne muscular dystrophy
- DOI
- 10.1186/s40360-026-01178-0
- Published
- 2026-06-30
- Container
- BMC Pharmacology and Toxicology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s40360-026-01178-0,
title = {Meta-analysis of clinical trials assessing the safety of pharmacological treatments for muscular degeneration in Duchenne muscular dystrophy},
author = {Gerard Ompad and Petra Maria Saura and Nicole Sonne Heckmann and Andrea Rossi and Elena Olmastroni and Manuela Casula and Maurizio Sessa},
year = {2026},
journal = {BMC Pharmacology and Toxicology},
doi = {10.1186/s40360-026-01178-0},
url = {https://doi.org/10.1186/s40360-026-01178-0}
}RIS
TY - JOUR TI - Meta-analysis of clinical trials assessing the safety of pharmacological treatments for muscular degeneration in Duchenne muscular dystrophy AU - Gerard Ompad AU - Petra Maria Saura AU - Nicole Sonne Heckmann AU - Andrea Rossi AU - Elena Olmastroni AU - Manuela Casula AU - Maurizio Sessa PY - 2026 JO - BMC Pharmacology and Toxicology DO - 10.1186/s40360-026-01178-0 UR - https://doi.org/10.1186/s40360-026-01178-0 ER -
APA
Ompad, G., Saura, P. M., Heckmann, N. S., Rossi, A., Olmastroni, E., Casula, M., & Sessa, M. (2026). Meta-analysis of clinical trials assessing the safety of pharmacological treatments for muscular degeneration in Duchenne muscular dystrophy. BMC Pharmacology and Toxicology. https://doi.org/10.1186/s40360-026-01178-0
Source records
- crossref · retrieved 2026-09-25T16:47:54.512Z